Memantine-induced Myoclonus in a Patient with Alzheimer Disease
نویسندگان
چکیده
BACKGROUND Myoclonus can be a clinical manifestation of numerous neurodegenerative disorders and an adverse drug reaction to medications used in their treatment. CASE REPORT Herein, we report memantine-induced myoclonus in a patient with Alzheimer disease. The myoclonus seen in our patient was generalized (proximal limbs and trunk), present at rest and with action, and stimulus sensitive. A structured evaluation with the Unified Myoclonus Rating Scale showed that the myoclonus had no significant effect on functional capacity. After discontinuation of memantine, myoclonus slowly resolved over the course of several weeks. DISCUSSION Memantine may cause myoclonus in susceptible individuals.
منابع مشابه
Longitudinal medication usage in Alzheimer disease patients.
This study examined in detail patterns of cholinesterase inhibitors (ChEIs) and memantine use and explored the relationship between patient characteristics and such use. Patients with probable Alzheimer disease AD (n=201) were recruited from the Predictors Study in 3 academic AD centers and followed from early disease stages for up to 6 years. Random effects logistic regressions were used to ex...
متن کاملFebrile myoclonus jerk in children with COVID-19 infection: letter to editor
Dear Editor The new coronavirus infection has spread rapidly around the world. The range of symptoms of this disease in children is from asymptomatic infection to severe respiratory or multiple systems failure, the common symptoms of which were different in each peak and in each strain. In Omicron strain fever without localize sign; involvement of the nervous system (seizures, headache, encepha...
متن کاملUtilization of antihypertensives, antidepressants, antipsychotics, and hormones in Alzheimer disease.
This study explores the longitudinal relationship between patient characteristics and use of 4 drug classes (antihypertensives, antidepressants, antipsychotics, and hormones) that showed significant changes in use rates over time in patients with Alzheimer disease. Patient/caregiver-reported prescription medication usage was categorized by drug class for 201 patients from the Predictors Study. ...
متن کاملLongitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine
OBJECTIVE To study the feasibility of multimodal neuroimaging in mild to moderate Alzheimer disease (AD) and to estimate the size of possible treatment effects of memantine on potential functional, structural and metabolic biomarkers of disease progression. METHODS In this randomised, double-blind, placebo-controlled pilot study, 36 patients with moderate AD received 52 weeks of memantine (20...
متن کاملDoes this patient have Alzheimer disease? Diagnosing and treating dementia.
Alzheimer disease follows a pattern of gradual cognitive, behavioral, and functional decline. Other causes of dementia have overlapping presentations, but with important differences. Most patients with mild to moderate dementia should be treated with cholinesterase inhibitors to temporarily stabilize symptoms and delay clinically important end points. Memantine, an N-methyl-D-aspartate antagoni...
متن کامل